Chylomicron processing in familial dysbetalipoproteinemia and familial combined hyperlipidemia studied with vitamin A and E as markers: a new physiological concept

被引:7
|
作者
Demacker, PNM [1 ]
Hectors, MPC [1 ]
Stalenhoef, AFH [1 ]
机构
[1] Univ Nijmegen Hosp, Dept Med, Div Gen Internal Med, NL-6500 HB Nijmegen, Netherlands
关键词
lipoproteins; apolipoprotein B-48; lipid transfer or diffusion; postprandial phase; vitamin A; vitamin E; familial dysbetalipoproteinemia; familial combined hyperlipidemia;
D O I
10.1016/S0021-9150(99)00326-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In previous work we identified a transfer/diffusion process occurring in the postprandial state that more or less contributes to the accumulation of beta-VLDL in familial dysbetalipoproteinemia (FD). Here we present a new theoretical concept underlying chylomicron processing developed on the basis of extended quantitative analyses of fat loading experiments, with both vitamins A and E, performed in patients with familial combined hyperlipidemia (FCH) in comparison to patients with FD and control subjects. Recovery of triglycerides from the fat load in the plasma triglyceride pool was < 4%, indicating a very effective lipolysis process with an active remnant generation. Vitamin A from the fat load was, over 48 h, quantitatively recovered in the plasma lipoprotein pool; vitamin E was recovered to 22-41%. Nevertheless, transfer/diffusion of both vitamins showed similar patterns. At equilibrium, their contents correlated strongly with the lipoprotein concentrations, the slopes being similar for control subjects and both groups of patients. Only in those FD patients with the highest lipid values, did the vitamin A/lipoprotein mass ratio in the Sf > 100 fraction deviate from the total group mean. In the Sf 15-100 fraction, most specific for 'remnants', vitamin A/cholesterol ratios for all subjects were uniform proving that beta-VLDL formation is a thermodynamic process regulated by concentration gradients and the lipophilicity of lipoprotein constituents, not a typical feature for patients with FD. In patients with FD, vitamin A in the plasma pool was recovered excessively (276%) in line with recognition in Various pools as a result of the transfer/diffusion process in plasma. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:169 / 180
页数:12
相关论文
共 32 条
  • [21] Vascular remodeling and prothrombotic markers in subjects affected by familial combined Hyperlipidemia and/or metabolic syndrome in primary prevention for cardiovascular disease
    Cicero, Arrigo F. G.
    Derosa, Giuseppe
    Manca, Marco
    Bove, Marilisa
    Borghi, Claudio
    Gaddi, Antonio V.
    ENDOTHELIUM-JOURNAL OF ENDOTHELIAL CELL RESEARCH, 2007, 14 (4-5): : 193 - 198
  • [22] Changes in paraoxonase and apolipoproteins A I, A II, B, CIII, E during therapy of combined familial hyperlipidemia by ciprofibrate
    Turay, J
    Grniaková, V
    Válka, J
    ATHEROSCLEROSIS, 1999, 144 : 25 - 25
  • [23] New genetic variants in the apoA-I and apoC-III genes and familial combined hyperlipidemia
    Groenendijk, M
    Cantor, RM
    De Bruin, TWA
    Dallinga-Thie, GM
    JOURNAL OF LIPID RESEARCH, 2001, 42 (02) : 188 - 194
  • [24] Increased plasma xanthine oxidase activity is related to nuclear factor kappa beta activation and inflammatory markers in familial combined hyperlipidemia
    Martinez-Hervas, S.
    Real, J. T.
    Ivorra, C.
    Priego, A.
    Chaves, F. J.
    Pallardo, F. V.
    Vina, J. R.
    Redon, J.
    Carmena, R.
    Ascaso, J. F.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2010, 20 (10) : 734 - 739
  • [25] Increased levels of xanthin oxidase activity are related to the activation of the nuclear factor kappa beta and to the inflammatory markers in the combined familial hyperlipidemia
    Martin, Beatriz
    CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2010, 22 (02): : 79 - 80
  • [26] Apolipoprotein E polymorphism influences lipid phenotypic expression, but not the low density lipoprotein subfraction distribution in familial combined hyperlipidemia
    Bredie, SJH
    Vogelaar, JM
    Demacker, PNM
    Stalenhoef, AFH
    ATHEROSCLEROSIS, 1996, 126 (02) : 313 - 324
  • [27] Mutations in the hepatic lipase, lipoprotein lipase and apo E but not the insulin receptor are susceptibility alleles modifying familial combined hyperlipidemia
    Gehrisch, S
    Kostka, H
    Julius, U
    Hanefeld, M
    Schroeder, HE
    Jaross, W
    ATHEROSCLEROSIS, 1998, 138 : S6 - S6
  • [28] Expression of human apolipoprotein A-II in apolipoprotein E-deficient mice induces features of familial combined hyperlipidemia
    Escolà-Gil, JC
    Julve, J
    Marzal-Casacuberta, A
    Ordóñez-Llanos, J
    González-Sastre, F
    Blanco-Vaca, F
    JOURNAL OF LIPID RESEARCH, 2000, 41 (08) : 1328 - 1338
  • [29] Increased plasma levels of oxysterols, in vivo markers of oxidative stress, in patients with familial combined hyperlipidemia: Reduction during atorvastatin and fenofibrate therapy
    Arca, Marcello
    Natoli, Silvia
    Micheletta, Fausta
    Riggi, Sara
    Di Angelantonio, Emanuele
    Montali, Anna
    Antonini, Teresa Maria
    Antonini, Roberto
    Diczfalusy, Ulf
    Iuliano, Luigi
    FREE RADICAL BIOLOGY AND MEDICINE, 2007, 42 (05) : 698 - 705
  • [30] Plasma PAI-1 levels are independently related to fatty liver and hypertriglyceridemia in familial combined hyperlipidemia, involvement of apolipoprotein E
    Brouwers, Martijn C. G. J.
    Govers-Riemslag, Jose
    Schalkwijk, Casper G.
    van Greevenbroek, Marleen M. J.
    van der Kallen, Carla J. H.
    Bekers, Otto
    van Dieijen-Visser, Marja P.
    ten Oever, Jaap
    Bilderbeek-Beckers, Monique A. L.
    de Bruin, Tjerk W. A.
    ten Cate, Hugo
    Stehouwer, Coen D. A.
    THROMBOSIS RESEARCH, 2008, 122 (04) : 466 - 472